JMT106 Injection in the Treatment of Advanced Solid Tumors

Clinical trial NCT07275073 · RECRUITING

Trial details

NCT number: NCT07275073
Sponsor: Shanghai JMT-Bio Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Lung Squamous Cell Carcinoma Hepatocellular Carcinoma

Start date: 2025-09-25
Primary completion: 2026-11-05
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.